FDA Expands Emergency Use Authorization For Regeneron Pharmaceutical’s COVID-19 Monoclonal Antibody Treatment

Reuters (7/30, Roy) reported the FDA “has expanded the emergency use authorization of Regeneron Pharmaceuticals Inc’s COVID-19 antibody cocktail, enabling its use as a preventive treatment for the illness in certain people.” The company “said the authoriz...